Assembly Biosciences, Inc. (ASMB)
Assembly Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Assembly Biosciences, Inc. (ASMB) is a Biotechnology company based in US with a market capitalization of $420.7M. Revenue grew 153.5% year-over-year and free cash flow was negative at -$41.2M. This page tracks ASMB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 73 employees · IPO Dec 17, 2010
Valuation
Valuation & price
$28.65as of May 17, 2026· -25.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.03
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$420.7M
Market cap
153.5%
Revenue growth (YoY)
99.8%
Gross margin
-$41.2M
Free cash flow (USD)
-$245.5M
Net debt
Net cash position
86.7%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 7, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJun 18, 2026Filing
Insider Sell $674Bjorkquist Jeanette M · PFO and PAO · $674.3
- 8-K eventJun 5, 2026Filing
Stockholder Meeting Results
- 8-K eventMay 26, 2026Filing
Securities Offering
- 8-K eventMay 22, 2026Filing
Clinical Development Expansion
- 8-K eventMay 7, 2026Filing
Earnings Release
- Quarterly reportMay 7, 2026Filing
10-Q Filed
Questions
Frequently asked questions
What is Assembly Biosciences, Inc.'s market cap?
Assembly Biosciences, Inc. (ASMB) has a market capitalization of $420.7M.
What is ASMB's P/E ratio?
A meaningful P/E ratio is not available for ASMB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is ASMB's price-to-book (P/B) ratio?
ASMB trades at 2.03 times book value per share.
Are insiders buying ASMB stock?
SEC Form 4 filings show no open-market insider buys at Assembly Biosciences, Inc. in the last 90 days (1 sell).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.